CD Bioparticles Announces Advanced Engineering Platform for OMV-Based Bacterial Vaccine Development
CD Bioparticles launches comprehensive OMV-Based Bacterial Vaccines Development services for infectious disease and oncology research. NEW YORK, NY, UNITED STATES, January 26, 2026 /EINPresswire.com/ -- CD Bioparticles, a leading manufacturer …